-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
Intuitive Surgical delivered robust Q1 2026 results with non-GAAP EPS of $2.50, beating the $2.11 consensus estimate (+38% Y/Y). Revenue surged to $2.77B (+23% Y/Y), above the $2.6B consensus view, driven by worldwide procedures growing 17% Y/Y with da Vinci procedures up 16% and Ion procedures accelerating 39%. System placements reached 431 da Vinci systems versus 367 in Q1 2025, while da Vinci 5 placements surged to 232 systems from 147, showing strong adoption of the next-generation platform. Management guided worldwide da Vinci procedure growth of 13.5%-15.5% with non-GAAP gross margins expected at 67.5%-68.5%, incorporating an estimated 1.0% revenue impact from current tariffs. The installed base reached 11,395 da Vinci systems (+12% Y/Y), while non-GAAP gross margin expanded to 67.8% from 66.4% and operating income grew 40% Y/Y, demonstrating strong operational leverage with a robust balance sheet of $7.98B in cash.